Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tigecycline vs Imipenem/Cilastatin in Complicated Intra-Abdominal Infections
NCT00081744Phase 3Completed
- Sponsor
- Pfizer
- Start
- Nov 2002
- Primary completion
- Aug 2004
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised, double-blind trial of tigecycline in Intra-abdominal infection (IAI) (2 arms), sponsored by Pfizer. Primary endpoint: Clinical Response at Test of Cure. Started Nov 2002; status: completed.
02
Drugs
tigecycline
03
Conditions
Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on NCT00081744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00081744.